JenniferMaloneyMD(She/Her)

Pediatric Allergy

Vice President of Clinical Sciences, Inflammation and Immunology, Clinical Lead of Dupilumab and Allergy Portfolio Regeneron

Dr. Maloney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Icahn School of Medicine at Mount SinaiFellowship, Allergy and Immunology, 2004 - 2006
Stony Brook Medicine/University HospitalResidency, Pediatrics, 2000 - 2004
Stony Brook University Health Sciences Center School of MedicineClass of 2000

PubMed

66 citations
A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay.
Jing Lin, Francesca M. Bruni, Zhiyan Fu, Jennifer M. Maloney, Ludmilla Bardina
The Journal of Allergy and Clinical Immunology. 2012-05-01
39 citations
Safety and tolerability of a short ragweed sublingual immunotherapy tablet
Hendrik Nolte, Niran J. Amar, David I. Bernstein, Bobby Q. Lanier, Peter S. Creticos
Annals of Allergy, Asthma & Immunology. 2014-07-01
103 citations
Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial.
Jennifer Maloney, David I. Bernstein, Harold S. Nelson, Peter S. Creticos, Jacques Hébert
Annals of Allergy, Asthma & Immunology. 2014-02-01

AAAAI: Novel Therapy Tackles Cat AllergyMarch 2nd, 2021
FARE Retreat: Experts Explore Food Allergy Treatment, TestingSeptember 26th, 2020